Market revenue in 2023 | USD 7.7 million |
Market revenue in 2030 | USD 9.7 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Microencapsulation |
Fastest growing segment | Nanoencapsulation |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Microencapsulation, Macroencapsulation, Nanoencapsulation |
Key market players worldwide | Merck KGaA, Otsuka Holdings Co Ltd, Austrianova, Sphere Fluidics, ViaCyte, BIO INX, Living Cell Technologies, Eli Lilly and Co, Isogen Life Science |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to live cell encapsulation market will help companies and investors design strategic landscapes.
Microencapsulation was the largest segment with a revenue share of 63.64% in 2023. Horizon Databook has segmented the Middle East & Africa live cell encapsulation market based on microencapsulation, macroencapsulation, nanoencapsulation covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa live cell encapsulation market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa live cell encapsulation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account